big4bio-logo-boston-2019-250

The Boston biomedical cluster includes 1000+ companies and is supported by research at leading universities and academic research centers; Kendall Square alone is home to more than 120 life science companies.

The sector has been encouraged through the investment of private and public capital, including the $1B commitment of the 2008 Massachusetts Life Sciences Act. Keep up with every development: Subscribe FREE to Big4Bio:Boston.

Subscribe
Subscribe

EVENT CENTER

sf-events
Boston is #1 when it comes to the number – and the quality — of events held here. Check out our event listings:

SPOTLIGHT

iStock_000008190739Small

Spotlight Q&A: Outlook Therapeutics — Developing First Ophthalmic Formulation of Bevacizumab for FDA Approval

LaVoieHealthScience Client Spotlight Following is a Q&A with Lawrence Kenyon, President, CEO and CFO of Outlook Therapeutics (NASDAQ: OTLK), a late-stage clinical biotech company focused on developing the first FDA-approved ophthalmic formulation of bevacizumab-vikg to treat wet age-related macular degeneration (wet AMD) and other retinal diseases.  By way of background for our readers, age-related macular […]

Read More

SPONSORS

iStock_000014574578Large
Check out our regional sponsors and partners – they are leaders in their fields, and we thank them for their support!

SOCIAL MEDIA

twitter-292994_640
We provide even more information by aggregating industry-related videos, podcasts, and more with our social channels: